These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1274 related items for PubMed ID: 20173740

  • 1. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
    Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA.
    Nat Cell Biol; 2010 Mar; 12(3):247-56. PubMed ID: 20173740
    [Abstract] [Full Text] [Related]

  • 2. Myc-modulated miR-9 makes more metastases.
    Khew-Goodall Y, Goodall GJ.
    Nat Cell Biol; 2010 Mar; 12(3):209-11. PubMed ID: 20173743
    [Abstract] [Full Text] [Related]

  • 3. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas.
    Huang R, Cheung NK, Vider J, Cheung IY, Gerald WL, Tickoo SK, Holland EC, Blasberg RG.
    FASEB J; 2011 Dec; 25(12):4138-49. PubMed ID: 21856782
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS, Zheng YJ, Wang J, Zhao JY, Yang DK, Liu ZS.
    J Exp Clin Cancer Res; 2019 Feb 21; 38(1):97. PubMed ID: 30791932
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA, Venturutti L, Huang YW, Schillaci R, Huang TH, Elizalde PV.
    Breast Cancer Res; 2012 May 14; 14(3):R77. PubMed ID: 22583478
    [Abstract] [Full Text] [Related]

  • 6. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.
    Buechner J, Tømte E, Haug BH, Henriksen JR, Løkke C, Flægstad T, Einvik C.
    Br J Cancer; 2011 Jul 12; 105(2):296-303. PubMed ID: 21654684
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S, Paryan M, Arefian E, Vasei M, Ghanbarian H, Mahdian R, Karimipoor M, Soleimani M.
    Tumour Biol; 2016 Jul 12; 37(7):8993-9000. PubMed ID: 26758430
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
    Sun B, Fan Y, Yang A, Liang L, Cao J.
    J Cell Mol Med; 2019 Sep 12; 23(9):5934-5948. PubMed ID: 31298493
    [Abstract] [Full Text] [Related]

  • 9. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang Y, Gu Q, Dong X, Liu F, Zhang Y, Li X.
    Sci Rep; 2016 Mar 16; 6():23091. PubMed ID: 26980408
    [Abstract] [Full Text] [Related]

  • 10. MYC-microRNA-9-metastasis connection in breast cancer.
    Almeida MI, Reis RM, Calin GA.
    Cell Res; 2010 Jun 16; 20(6):603-4. PubMed ID: 20502442
    [No Abstract] [Full Text] [Related]

  • 11. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
    Chava S, Reynolds CP, Pathania AS, Gorantla S, Poluektova LY, Coulter DW, Gupta SC, Pandey MK, Challagundla KB.
    Mol Oncol; 2020 Jan 16; 14(1):180-196. PubMed ID: 31637848
    [Abstract] [Full Text] [Related]

  • 12. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.
    Png KJ, Halberg N, Yoshida M, Tavazoie SF.
    Nature; 2011 Dec 14; 481(7380):190-4. PubMed ID: 22170610
    [Abstract] [Full Text] [Related]

  • 13. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.
    Zhou B, Xu H, Xia M, Sun C, Li N, Guo E, Guo L, Shan W, Lu H, Wu Y, Li Y, Yang D, Weng D, Meng L, Hu J, Ma D, Chen G, Li K.
    Front Med; 2017 Jun 14; 11(2):214-222. PubMed ID: 28470508
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
    Buechner J, Henriksen JR, Haug BH, Tømte E, Flaegstad T, Einvik C.
    Differentiation; 2011 Jan 14; 81(1):25-34. PubMed ID: 20980091
    [Abstract] [Full Text] [Related]

  • 15. MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.
    Lovén J, Zinin N, Wahlström T, Müller I, Brodin P, Fredlund E, Ribacke U, Pivarcsi A, Påhlman S, Henriksson M.
    Proc Natl Acad Sci U S A; 2010 Jan 26; 107(4):1553-8. PubMed ID: 20080637
    [Abstract] [Full Text] [Related]

  • 16. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.
    DiFeo A, Narla G, Camacho-Vanegas O, Nishio H, Rose SL, Buller RE, Friedman SL, Walsh MJ, Martignetti JA.
    Oncogene; 2006 Sep 28; 25(44):6026-31. PubMed ID: 16702959
    [Abstract] [Full Text] [Related]

  • 17. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
    Kong LM, Liao CG, Zhang Y, Xu J, Li Y, Huang W, Zhang Y, Bian H, Chen ZN.
    Cancer Res; 2014 Jul 15; 74(14):3764-78. PubMed ID: 24906624
    [Abstract] [Full Text] [Related]

  • 18. miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
    Cui F, Wang S, Lao I, Zhou C, Kong H, Bayaxi N, Li J, Chen Q, Zhu T, Zhu H.
    Oncol Rep; 2016 Jul 15; 36(1):487-93. PubMed ID: 27222350
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.
    Song Y, Li J, Zhu Y, Dai Y, Zeng T, Liu L, Li J, Wang H, Qin Y, Zeng M, Guan XY, Li Y.
    Oncotarget; 2014 Nov 30; 5(22):11669-80. PubMed ID: 25375090
    [Abstract] [Full Text] [Related]

  • 20. Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation.
    Koppen A, Ait-Aissa R, Hopman S, Koster J, Haneveld F, Versteeg R, Valentijn LJ.
    Cancer Lett; 2007 Oct 28; 256(2):218-28. PubMed ID: 17643814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.